The structure and function of Ca^<2+>-permeable nonselective cation channels

Ca^2-渗透性非选择性阳离子通道的结构和功能

基本信息

  • 批准号:
    11670086
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

The purpose of the present study is to clarify the structure, function, pharmacology and functional significance of Ca^<2+> channels activated bv endothelin-1 (ET-1) in vascular smooth muscle cells (VSMCs). ET-1 activated three types of Ca^<2+>-permeable channel in A7r5 cells derived from rat thoracic aortic smooth muscle cells : two types of nonselective cation channel (designated NSCC-1 and NSCC-2) and store-operated Ca^<2+> channel (SOCC). Importantly, these channels were discriminated by two drugs like SK&F 96365 and LOE 908 belonging to blockers of the "so-called" receptor-operated Ca^<2+> channel. Using these blockes, contractions and inreases in the intracellular free Ca^<2+> concentration induced by ET-1 in VSMCs were found to actually involve Ca^<2+> entry through NSCC-1, NSCC-2 and SOCC.To isolate cDNAs encoding these channels, we used two strategies : one is PCR-based cloning and the other is expression cloning with Xenopus oocytes. In the former strategy, the conserved region of Ca^<2+> channels called transient receptor potentials (trp) was used as probe. In the latter strategy, a screening method using ^<45>Ca^<2+> uptake was developed to specifically detect Ca^<2+> entry. In the PCR-based method, two forms of cDNA (trp 4 and its putative splice variant designated trp 4Δ) were isolated. The sequence of trp 4 was essentially similar to that isolated from other tissues, but trp 4Δ was unique in that it lacks part of the sequence corresponding to the first and second membrane spanning region. When expressed in the oocytes and HEK 293 cells, both cDNAs were functionally intact. They were activated by store depletion, and showed the same pharmacological properties as those of SOCC.Notably, trp 4Δ showed larger responses than trp 4. In the expression cloning strategy, cDNA library from VSMCs was screened and five positive clones were obtained. The structure and function of these clones are being determined.
本研究的目的是阐明血管平滑肌细胞(VSMCs)内皮素-1(ET-1)激活的钙通道的结构、功能、药理作用和功能意义。ET-1在大鼠胸主动脉平滑肌细胞A7r5细胞上激活三种钙离子通透性通道:非选择性阳离子通道(NSCC-1和NSCC-2)和钙离子通道(SOCC)。重要的是,这些通道被SK&F 96365和LOE 908这两种药物区分开来,这两种药物属于“所谓的”受体操作的钙通道阻滞剂。利用这些阻滞剂,我们发现ET-1引起的VSMC内游离钙离子浓度的升高和收缩实际上涉及到通过NSCC-1、NSCC-2和SOCC进入细胞内。为了分离编码这些通道的cDNAs,我们采用了两种策略:一种是基于PCR的克隆,另一种是利用非洲爪哇卵母细胞进行表达克隆。在前一种策略中,以钙通道的保守区称为瞬时受体电位(Trp)作为探针。在后一种策略中,开发了一种使用^&lt;45&gt;Ca^&lt;2+&gt;摄取的筛选方法来特异性地检测Ca^&lt;2+&gt;条目。在基于聚合酶链式反应的方法中,分离到两种形式的cDNATrP4及其可能的剪接变异体TrP4Δ。Trp 4的序列与从其他组织中分离到的序列基本相似,但Trp 4的Δ是独一无二的,因为它缺少与第一和第二膜跨越区域相对应的部分序列。当在卵母细胞和HEK 293细胞中表达时,这两个cDNA在功能上是完整的。其药理活性与SOCC相同。值得注意的是,Trp-4的Δ活性高于Trp-4。这些克隆的结构和功能正在确定中。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Soichi Miwa: "Ca^<2+> Entry Channels in Rat Thoracic Aortic Smooth Muscle Cells Activated by Endothelin-1"Jpn J Pharmacol.. 80. 281-288 (1999)
Soichi Miwa:“内皮素-1激活的大鼠胸主动脉平滑肌细胞中的Ca^<2>进入通道”Jpn J Pharmacol.. 80. 281-288 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Soichi Miwa: "A Specific Blocker of Nonselective Cation Channel"Cardiovascular Drug Reviews. 18. 61-72 (2000)
Soichi Miwa:“非选择性阳离子通道的特异性阻断剂”心血管药物评论。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Soichi Miwa: "Pharmacological Properties of Calcium Entry Channels in A7r5 Cells Activated by Endothelin-1"Journal of Cardiovascular Pharmacology. 36. S107-S109 (2000)
Soichi Miwa:“内皮素-1 激活的 A7r5 细胞中钙进入通道的药理学特性”心血管药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Xiao-Feng Zhang: "Endothelin-1-Induced Contraction of Rat Thoracic Aorta Depends on Calcium Entry Through Three Types of Calcium Channel"Journal of Cardiovascular Pharmacology. 36. S105-S106 (2000)
张晓峰:“内皮素-1诱导的大鼠胸主动脉收缩依赖于通过三种钙通道的钙进入”心血管药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lee,K.: "Pharmacological characterization of receptor-mediated Ca^<2+> entry in endothelin-1-induced catecholamine release from cultured bovine adrenal chromaffin cells"Naunyn-Schmiedeberg's Arch Pharmacol. 360. 616-622 (1999)
Lee,K.:“内皮素-1诱导的培养牛肾上腺嗜铬细胞释放儿茶酚胺中受体介导的Ca ^ 2 进入的药理学特征”Naunyn-Schmiedebergs Arch Pharmacol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIWA Soichi其他文献

MIWA Soichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIWA Soichi', 18)}}的其他基金

Elucidation of molecular mechanism of cell damage by cigarette smoke extract and development of cigarette smoke detoxification methods
香烟烟雾提取物损伤细胞的分子机制的阐明及香烟烟雾解毒方法的开发
  • 批准号:
    23659129
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study of the regulatory mechanism of ETAR and ETBR level by receptor binding protein and the relevance between clinical significance and endothelin receptor level.
研究受体结合蛋白对ETAR、ETBR水平的调节机制及临床意义与内皮素受体水平的相关性。
  • 批准号:
    21390068
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for novel signal molecules which are directly activated by endothelin receptor
寻找内皮素受体直接激活的新型信号分子
  • 批准号:
    18390072
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structure and function of receptor-operated Ca^<2+> channels and development of specific blockers of the channels
受体操纵的 Ca^2 通道的结构和功能以及该通道的特异性阻断剂的开发
  • 批准号:
    15390075
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The structure and function of voltage-independent Ca^<2+> channels involved in vascular contractions
参与血管收缩的电压依赖性Ca^2通道的结构和功能
  • 批准号:
    13470017
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
  • 批准号:
    10586599
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
暗蛋白缺陷的乳腺上皮细胞产生分泌因子,促进肺血管平滑肌细胞转移前微环境的形成
  • 批准号:
    10749467
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
  • 批准号:
    10910432
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
  • 批准号:
    10733477
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
MicroRNA elucidation of the pathogenesis of vascular smooth muscle cell calcification from postprandial hyperglycemia
MicroRNA阐明餐后高血糖血管平滑肌细胞钙化的发病机制
  • 批准号:
    23K06912
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification
血管平滑肌细胞表型调节和钙化中的蛋白质精氨酸甲基化
  • 批准号:
    10734531
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Understanding how matrix rigidity and cytoskeletal crosstalk regulate vascular smooth muscle cell ageing
了解基质刚性和细胞骨架串扰如何调节血管平滑肌细胞衰老
  • 批准号:
    2868506
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Studentship
Novel molecular mechanisms of vascular smooth muscle cell-mediated large and small artery calcification
血管平滑肌细胞介导大小动脉钙化的新分子机制
  • 批准号:
    10670415
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
  • 批准号:
    10683796
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis
RNA靶位点寡核苷酸倾斜免疫细胞促进血管平滑肌细胞稳态
  • 批准号:
    10593490
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了